KONTROLLIERTE FREISETZUNG PHENOLISCHER OPIOIDE

Patent europeic · EP2046393 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2046393
Numer da la dumonda
EP07797745
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
24-05-2007
Publitgà
15-04-2009
Concedì
12-02-2014
La protecziun finescha il pli tard
23-05-2027
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61K 47/48 (2006.01)
A61P 25/04 (2006.01)
Prioritad
US 809082 P 26.05.2006
US 901795 P 16.02.2007
Dumonda PCT
PCT/US2007/069683 24.05.2007
Publicaziun PCT
WO2007/140272 06.12.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 02-06-2023

    Midada

    Published in Swissreg on 02.06.2023

  5. 12-02-2014

    Concedì

    Published in Swissreg on 12.02.2014

Partidas

Possessur

Signature Therapeutics, Inc.

1731 Embarcadero Road, Suite 200, Palo Alto, CA 94303, US

Inventur

JENKINS, Thomas E.

Half Moon Bay, CA 94019, US

KOLESNIKOV, Aleksandr

San Francisco, California 94121, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.